Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Revenue (2016 - 2025)

Lisata Therapeutics filings provide 11 years of Revenue readings, the most recent being $130000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 87.0% year-over-year to $130000.0, compared with a TTM value of $200000.0 through Dec 2025, down 80.0%, and an annual FY2025 reading of $200000.0, down 80.0% over the prior year.
  • Revenue hit $130000.0 in Q4 2025 for Lisata Therapeutics, up from $70000.0 in the prior quarter.
  • The five-year high for Revenue was $1.0 million in Q4 2024, with the low at $70000.0 in Q2 2025.